Right ventricular dysfunction

Current Opinion in Critical Care

Volumn 13, Issue 5, 2007, Pages 532-540

  Woods, Justin ^a   Monteiro, Patricia ^a   Rhodes, Andrew ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Echocardiography; Levosimendan; Right heart catheter; Right ventricular dysfunction

Indexed keywords

BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; DOBUTAMINE; GLYCERYL TRINITRATE; HYDRALAZINE; HYPERTENSIVE FACTOR; LEVOSIMENDAN; MILRINONE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN E1; TADALAFIL; VARDENAFIL;

ADULT RESPIRATORY DISTRESS SYNDROME; AMNION FLUID EMBOLISM; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; CARDIOMYOPATHY; CLINICAL TRIAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HUMAN; INTENSIVE CARE; LUNG EMBOLISM; MITRAL VALVE REGURGITATION; REVIEW; THORAX RADIOGRAPHY;

CARDIOTONIC AGENTS; CARDIOVASCULAR AGENTS; ECHOCARDIOGRAPHY; HEART-ASSIST DEVICES; HUMANS; MAGNETIC RESONANCE IMAGING; NATRIURETIC PEPTIDES; RESPIRATION, ARTIFICIAL; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 34548442031     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e3282efd5a6     Document Type: Review

References (89)

1. Rigolin VH, Robiolo PA, Wilson JS, et al. The forgotten chamber: the importance of the right ventricle. Cathet Cardiovasc Diagn 1995; 35:18-28.
2. Cecconi M, Johnston E, Rhodes A. What role does the right side of the heart play in circulation? Crit Care 2006; 10 (Suppl 3):S5.
3. Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26:384-416.
4. Beaulieu Y. Bedside echocardiography in the assessment of the critically ill. Crit Care Med 2007; 35 (Suppl 5):S235-S249.
5. Wood KE. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 2002; 121:877-905.
6. Brieke A, DeNofrio D. Right ventricular dysfunction in chronic dilated cardiomyopathy and heart failure. Coron Artery Dis 2005; 16:5-11.
7. Steendijk P. Right ventricular function and failure: Methods, models, and mechanisms. Crit Care Med 2004; 32:1087-1089.
8. Zehender M, Kasper W, Kauder E, et al. Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction. N Engl J Med 1993; 328:981-988.
9. Kasper W, Konstantinides S, Geibel A, et al. Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism. Heart 1997; 77:346-349.
10. De Groote P, Millaire A, Foucher-Hossein C, et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol 1998; 32:948-954.
11. Budev M, Arroliga A, Wiedemann H, et al. Cor pulmonale: an overview. Semin Respir Crit Care Med 2003; 24:233-244.
12. Zornoff LAM, Skali H, Pfeffer MA, et al. Right ventricular dysfunction and risk of heart failure and mortality following myocardial infarction. J Am Coll Cardiol 2002; 39:1450-1455.
13. Mehta SR, Eikelboom JW, Natarajan MK, et al. Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction. J Am Coll Cardiol 2001; 37:37-43.
14. Bleasdale R, Turner M, Mumford C, et al. Left ventricular pacing minimizes diastolic ventricular interaction, allowing improved preload-dependent systolic performance. Circulation 2004; 110:2395-2400.
15. Piazza G, Goldhaber S. The acutely decompensated right ventricle: pathways for diagnosis and management. Chest 2005; 128:1836-1852.
16. Parker MM, McCarthy KE, Ognibene FP, Parrillo JE. Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 1990; 97:126-131.
17. Krishnagopalan S, Kumar A, Parrillo JE, Kumar A. Myocardial dysfunction in the patient with sepsis. Curr Opin Crit Care 2002; 8:376-388.
18. Vieillard-Baron A, Schmitt JM, Augarde R, et al. Acute cor pulmonale in acute respiratory distress syndrome submitted to protective ventilation: incidence, clinical implications, and prognosis. Crit Care Med 2001; 29:1551-1555.
19. McNeil K, Dunning J, Morrell N. The pulmonary physician in critical care 13: The pulmonary circulation and right ventricular failure in the ITU. Thorax 2003; 58:157-162.
20. Jardin F, Viellard-Baron A. Monitoring of right sided heart function. Curr Opin Crit Care 2005; 11:271-279.
21. Cordingley J, Keogh B. The pulmonary physician in critical care 8: Ventilatory management of ALI/ARDS. Thorax 2002; 57:729-734.
22. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-1308.
23. Via G, Braschi A. Pathophysiology of severe pulmonary hypertension in the critically ill patient. Minerva Anestesiol 2004; 70:233-237.
24. Stobierska-Dzierzek B, Awad H, Michler RE. The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol 2001; 38:923-931.
25. Dell'Italia LJ. Reperfusion for right ventricular infarction. N Engl J Med 1998; 338:978-980.
26. Bristow MR, Zisman LS, Lowes BD, et al. The pressure-overloaded right ventricle in pulmonary hypertension. Chest 1998; 114:101S-106S.
27. Goldstein J. Pathophysiology and management of right heart ischemia. J Am Coll Cardiol 2002; 40:841-853.
28. Fischer LG, Aken HV, Burkle H. Management of pulmonary hypertension: Physiological and pharmacological considerations for anesthesiologists. Anesth Analg 2003; 96:1603-1616.
29. Weitzenblum E. Chronic cor pulmonale. Heart 2003; 89:225-230.
30. Vizza CD, Lynch JP, Ochoa LL, et al. Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest 1998; 113:576-583.
31. Mebazaa A, Karpati P, Renaud E, et al. Acute right ventricular failure: from pathophysiology to new treatments. Intensive Care Med 2004; 30:185-196.
32. Bleeker GB, Steendijk P, Holman ER, et al. Assessing right ventricular function: the role of echocardiography and complementary technologies. Heart 2006; 92:i19-i26.
33. McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP Evidence-Based Clinical Practice Guidelines. Chest 2004; 126:14S-34S.
34. Rathi V, Biederman R. Imaging of ventricular function by cardiovascular magnetic resonance. Curr Cardiol Rep 2004; 6:55-61.
35. Boxt LM, Katz FJ, Kolb T. Direct quantitation of right and left ventricular volumes with nuclear magnetic resonance imaging in patients with primary pulmonary hypertension. J Am Coll Cardiol 1992; 19:1508-1515.
36. Bleeker G, Steendijk P, Holman E, et al. Acquired right ventricular dysfunction. Heart 2006; 92:i14-i18. This is a review of the available imaging modalities for the assessment of the right ventricle.
37. Cheatham M, Nelson L, Chang M, et al. Right ventricular end-diastolic volume index as a predictor of preload status in patients on positive end-expiratory pressure. Crit Care Med 1998; 26:1801-1806.
38. Bellenger N, Burgess M, Ray S, et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance. Are they interchangeable? Eur Heart J 2000; 21:1387-1396.
39. Kucher N, Goldhaber SZ. Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation 2003; 108:2191-2194.
40. Norozi K, Buchhorn R, Kaiser C, et al. Plasma N-terminal pro-brain natriuretic peptide as a marker of right ventricular dysfunction in patients with tetralogy of fallot after surgical repair. Repair Chest 2005; 128:2563-2570.
41. Binder L, Pieske B, Olschewski M, et al. N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation 2005; 112:1573-1579.
42. Krüger S, Graf J, Merx MW, et al. Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism. Am Heart J 2004; 147:60-65.
43. Clerico A, Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem 2004; 50:33-50.
44. Nagaya N, Nishikimi T, Okano Y, et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998; 31:202-208.
45. Phua J, Lim TK, Lee KH. B-type natriuretic peptide: issues for the intensivist and pulmonologist. Crit Care Med 2005; 33:2094-2103.
46. Tulevski I, Hirsch A, Sanson B, et al. Increased brain natriuretic peptide as a marker for right ventricular dysfunction in acute pulmonary embolism. Thromb Haemost 2001; 86:1193-1196.
47. Charpentier J, Luyt CE, Fulla Y, et al. Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 2004; 32:660-665.
48. Bendjelid K, Romand JA. Fluid responsiveness in mechanically ventilated patients: A review of indices used in intensive care. Intensive Care Med 2003; 29:352-360.
49. Coudray A, Romand JA, Treggiari M, Bendjelid K. Fluid responsiveness in spontaneously breathing patients: a review of indexes used in intensive care. Crit Care Med 2005; 33:2757-2762.
50. Michard F, Teboul JL. Predicting fluid responsiveness in ICU patients: a critical analysis of the evidence. Chest 2002; 121:2000-2008.
51. Mercat A, Diehl JL, Meyer G, et al. Hemodynamic effects of fluid loading in acute massive pulmonary embolism. Critical Care Medicine 1999; 27:540-544.
52. Follath F, Cleland JG, Just H, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study) (a randomised double-blind trial). Lancet 2002; 360:196-202.
53. Mebazaa A, Barraud D, Welschbillig S. Randomized clinical trials with levosimendan. Am J Cardiol 2005; 96 (suppl 6A):74G-79G.
54. Moiseyev VS, Poder P, Andrejevs N, et al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction (a randomized, placebo-controlled, double-blind study (RUSSLAN)). Eur Heart J 2002; 23:1422-1432.
55. Slawsky M, Colucci W, Gottlieb S, et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Circulation 2000; 102:2222-2227.
56. Mebazaa A, Nieminen M, Packer M, et al. For the SURVIVE investigators. Levosimendan vs dobutamine for patients with acute decompensated heart failure: The SURVIVE Randomized Trial. JAMA 2007; 297:1883-1891. This randomized controlled trial in severe heart failure comparing levosimendan and dobutamine demonstrated no significant outcome benefit for levosimendan over dobutamine.
57. Ukkonen H, Saraste M, Akkila J, et al. Myocardial efficiency during levosimendan infusion in congestive heart failure. Clin Pharmacol Ther 2000; 68:522-531.
58. Parissis J, Paraskevaidis I, Bistola V, et al. Effects of levosimendan on right ventricular function in patients with advanced heart failure. Am J Cardiol 2006; 98:1489-1492.
59. Morelli A, Teboul JL, Maggiore SM, et al. Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: A pilot study. Crit Care Med 2006; 34:2287-2293. This small pilot study looking at levosimendan in early ARDS illustrated the potential of this lusitropic agent as an effective therapy for right ventricular failure.
60. Bayram M, De Luca L, Massie MB, Gheorghiade M. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. Am J Cardiol 2005; 96 (Suppl 6A):47G-58G.
61. Haraldsson A, Kieler-Jensen N, Ricksten S. The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension. Anesth Analg 2001; 93:1439-1445.
62. Ng J, Finney S, Shulman R, et al. Treatment of pulmonary hypertension in the general adult intensive care unit: a role for oral sildenafil? Br J Anaesth 2005; 94:774-777.
63. Carvalho C, Barbas C, Medeiros D, et al. Temporal hemodynamic effects of permissive hypercapnia associated with ideal PEEP in ARDS. Am J Respir Crit Care Med 1997; 156:1458-1466.
64. Siobal M. Aerosolized prostacyclins. Respir Care 2004; 49:640-652.
65. Lowson S. Inhaled alternatives to nitric oxide. Anesthesiology 2002; 96:1504-1513.
66. Fattouch K, Sbraga F, Sampognaro R, et al. Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study. J Card Med 2006; 7:119-123.
67. Ricciardolo F, Sterk P, Gaston B, et al. Nitric oxide in health and disease of the respiratory system. Physiol Rev 2004; 84:731-765.
68. Kaisers U, Busch T, Deja M, et al. Selective pulmonary vasodilation in acute respiratory distress syndrome. Crit Care Med 2003; 31 (Suppl):S337-S347.
69. Bhorade S, Christenson J, O'Connor M, et al. Response to inhaled nitric oxide in patients with acute right heart syndrome. Am J Respir Crit Care Med 1999; 159:571-579.
70. Hare J, Shernan S, Body S, et al. Influence of inhaled nitric oxide on systemic flow and ventricular filling pressure in patients receiving mechanical circulatory assistance. Circulation 1997; 95:2250-2253.
71. Lepore J, Maroo A, Bigatello L, et al. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide. Chest 2005; 127:1647-1653.
72. Ghofrani H, Voswinckel R, Reichenberger F. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: A randomized prospective study. J Am Coll Cardiol 2004; 44:1488-1496.
73. Wilkins M, Paul G, Strange J, et al. Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study. Am J Respir Crit Care Med 2005; 171:1292-1297.
74. Lobato E, Beaver T, Muehlschlegel J, et al. Treatment with phosphodiesterase inhibitors type III and V: milrinone and sildenafil is an effective combination during thromboxane-induced acute pulmonary hypertension. Br J Anaesth 2006; 96:317-322.
75. Ghofrani HA, Wiedemann R, Rose F, et al. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med 2002; 136:515-522.
76. Pfisterer M. Rapid review: right ventricular involvement in myocardial infarction and cardiogenic shock. Lancet 2003; 362:392-394.
77. Kurzyna M, Dabrowski M, Bielecki D, et al. Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension. Chest 2007; 131:977-983.
78. Cazeau S, Leclercq C, Lavergne T, et al. The Multisite Stimulation in Cardiomyopathies (MUSTIC) study investigators, effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344:873-880.
79. Leclercq C, Kass D. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 2002; 39:194-201.
80. Abraham W, Fisher W, Smith A, et al., the MIRACLE Study Group. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346:1845-1853.
81. Bleasdale RA, Frenneaux MP. Cardiac resynchronisation therapy: when the drugs don't work. Heart 2004; 90:vi2-vi4.
82. Jardin F, Vieillard-Baron A. Right ventricular function and positive pressure ventilation in clinical practice: from hemodynamic subsets to respirator settings. Intensive Care Med 2003; 29:1426-1434.
83. Schmitt JM, Vieillard-Baron A, Augarde R, et al. Positive end-expiratory pressure titration in acute respiratory distress syndrome patients: impact on right ventricular outflow velocity measurements. Crit Care Med 2001; 29:1154-1158.
84. Ranieri VM, Dambrosio M, Brienza N. Intrinsic PEEP and cardiopulmonary interaction in patients with COPD and acute ventilatory failure. Eur Respir J 1996; 9:1283-1292.
85. Gattinoni L, Caironi P, Cressoni M, et al. Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med 2006; 354:1775-1786. The authors describe the use of computerized tomography to assess the recruitability of lung by the application of PEEP. They illustrate the variability within ARDS of recruitable lung segments and by inference the potential for harm with pulmonary overdistension from inappropriate ventilatory strategies.
86. Malbouisson LM, Muller JC, Constantin JM, et al. CT Scan ARDS Study Group: Computed tomography assessment of positive end-expiratory pressure-induced alveolar recruitment in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2001; 163:1444-1450.
87. Jardin F, Brun-Ney D, Hardy A, et al. Combined thermodilution and two-dimensional echocardiographic evaluation of right ventricular function during respiratory support with PEEP. Chest 1991; 99:162-168.
88. Higgins J, Estetter B, Holland D, et al. High-frequency oscillatory ventilation in adults: Respiratory therapy issues. Crit Care Med 2005; 33:S196-S203.
89. Griffiths M, Evans T. Inhaled nitric oxide therapy in adults. N Engl J Med 2005; 353:2683-2695.